Home › Trial NCT01371240
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
- Trial IDNCT01371240
- StatusWithdrawn
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorUniversity Hospitals Cleveland Medical Center
- Enrollment—
- Start date2011-06
- ConditionsPancreas Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.